Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing biopsy and aspiration for diagnosing joint infections in shoulder and elbow surgeries

Official title: A Diagnostic Test Accuracy Study Comparing Biopsy to Aspiration in Shoulder and Elbow Arthroplasty Revision Surgery (BASE Study)

Run by Wrightington, Wigan and Leigh NHS Foundation Trust · NCT06268795 · Data updated 2026-11-12

This study is testing whether using a needle to take fluid from the joint or doing a surgical biopsy is better for diagnosing infections in patients having shoulder or elbow surgeries.

More Periprosthetic Joint Infection trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment244 (estimated)
SponsorWrightington, Wigan and Leigh NHS Foundation Trust
Academic / other
Locations1 site (Wigan, Lancashire)
StatusRecruiting
StartedMarch 20, 2024
Main results expectedSeptember 1, 2028
Study endsSeptember 1, 2028
Registry record updatedNovember 9, 2026
Trial IDNCT06268795 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are scheduled for revision shoulder or elbow arthroplasty surgery.

Probably not a fit

Patients who are currently on antibiotic treatment or are pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the diagnostic accuracy of percutaneous aspiration versus open biopsy for detecting periprosthetic joint infection (PJI) in patients undergoing revision shoulder and elbow arthroplasty. It will utilize microbiological and histological methods to assess the effectiveness of joint aspiration as a pre-operative diagnostic tool. Given the challenges in diagnosing PJI, the study seeks to optimize the diagnostic pathway by integrating clinical findings, laboratory results, and imaging data. The findings could potentially inform better management strategies for patients facing this severe complication.

Why it matters

Potential benefit: If successful, this study could lead to more accurate and timely diagnoses of joint infections, improving treatment outcomes for patients.

How similar studies have gone: While studies have shown success in assessing diagnostic accuracy for hip and knee arthroplasties, this approach for shoulder and elbow arthroplasties is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged: 18 years or older.
* A participant is willing and able to give informed consent for participation in the study.
* Patient undergoing revision shoulder or elbow arthroplasty surgery.
* Previous anatomic total shoulder arthroplasty (TSA), shoulder hemiarthroplasty (HA), reverse total shoulder arthroplasty (RTSA), total elbow arthroplasty (TEA), distal humeral hemiarthroplasty (DHH) and radial head arthroplasty (RHA).

Exclusion Criteria:

* Refusal of consent.
* Antibiotic treatment was not stopped 2 weeks before aspiration or biopsy.
* Pregnancy.
* Part of any other trial with similar interventions unless previously agreed on with investigators.

Where it's running

  • Wrightington Wigan & Leigh Teaching Hospitals NHS Foundation Trust
    Wigan, Lancashire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.